Skip to main content

Resources tagged with “REDUCE”

Two Year Results: Reducing Chronic Pain Utilizing GORE® BIO-A® Hernia Plug in Inguinal Herniorrhaphy

Poster Presented at the Miscellaneous Session, American College of Surgeons’ 94th Annual Clinical Congress

PDF, 470.47 KB

Gore Announces Positive Results from REDUCE Clinical Study for PFO Closure

Study met its primary endpoint with PFO closure in conjunction with antiplatelet therapy, reducing recurrent stroke by > 75% over antiplatelet therapy alone

May 16, 2017

Gore REDUCE Clinical Study Completes Enrollment

Study of Closure of Patent Foramen Ovale (PFO) in Stroke Patients Reaches Major Milestone

Feb 25, 2015

Gore Marks Two-Year Primary Endpoint Follow-up Milestone in Study of GORE® CARDIOFORM Septal Occluder for Patent Foramen Ovale (PFO) Closure

Completion of follow -up paves way for REDUCE Clinical Study data submission to FDA for PFO indication

Mar 30, 2017